Ilan Ganot - Dec 2, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
4
Date filed
12/5/2022, 05:03 PM
Previous filing
May 4, 2022
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Stock Option (Right to Buy) Award $0 +13.3K $0.00 13.3K Dec 2, 2022 Common Stock 13.3K $6.77 Direct F1
transaction SLDB Restricted Stock Units Award $0 +6.33K $0.00 6.33K Dec 2, 2022 Common Stock 6.33K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option (the "Ganot Option") was granted on December 2, 2022 (the "Grant Date") and vests in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Separation Date (as defined in that certain Executive Transition and Separation Agreement between the issuer and Mr. Ganot, the "Ganot Agreement"); provided that in the event of a Change in Control (as defined in the Ganot Agreement) the Ganot Option shall accelerate in full.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "Ganot RSUs").
F3 The Ganot RSUs were granted on the Grant Date and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Separation Date (as defined in the Ganot Agreement); provided that in the event of a Change in Control (as defined in the Ganot Agreement) the Ganot RSUs shall accelerate in full.

Remarks:

Exhibit Index: 24.1 Power of Attorney